Characteristics of Staphylococcus aureus strains isolated in Poland in 1996 to 2004 that were deficient in species-specific proteins

Journal of Clinical Microbiology

Volumn 44, Issue 11, 2006, Pages 4018-4024

  Luczak Kadlubowska, Agnieszka ^a   Krzyszton Russjan, Jolanta ^b   Hryniewicz, Waleria ^a,b  

^a National Center of Quality Control in Microbiology   (Poland)

^b NATIONAL MEDICINES INSTITUTE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

COAGULASE; GLYCOPEPTIDE; TEICOPLANIN; THERMONUCLEASE; UNCLASSIFIED DRUG;

ARTICLE; CLFA GENE; CLFB GENE; CLUMPING FACTOR; COA GENE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE; GENOTYPE; HUMAN; HUNGARY; MOLECULAR CLONING; MULTILOCUS SEQUENCE TYPING; NONHUMAN; NUC GENE; PHENOTYPE; POLAND; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PULSED FIELD GEL ELECTROPHORESIS; SPA GENE; SPECIES DIFFERENCE; STAPHYLOCOCCUS AUREUS; STRAIN DIFFERENCE; STRAIN IDENTIFICATION; VARIABLE NUMBER OF TANDEM REPEAT;

BACTERIAL TYPING TECHNIQUES; COAGULASE; ELECTROPHORESIS, GEL, PULSED-FIELD; GLYCOPEPTIDES; HUMANS; MICROBIAL SENSITIVITY TESTS; PHENOTYPE; STAPHYLOCOCCUS AUREUS; TIME FACTORS;

STAPHYLOCOCCUS AUREUS;

EID: 33750948065     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01164-06     Document Type: Article

References (54)

1. Aires de Sousa, M., and H. de Lencastre. 2003. Evolution of sporadic isolates of methicillin-resistant Staphylococcus aureus (MRSA) in hospitals and their similarities to isolates of community-acquired MRSA. J. Clin. Microbiol. 41:3806-3815.
2. Aires de Sousa, M., M. Miragaia, I. S. Sanches, S. Avila, I. Adamson, S. T. Casagrande, M. C. Brandileone, R. Palacio, L. Dell'Acqua, M. Hortal, T. Camou, A. Rossi, M. E. Velazquez-Meza, G. Echaniz-Aviles, F. Solorzano-Santos, I. Heitmann, and H. de Lencastre. 2001. Three-year assessment of methicillin-resistant Staphylococcus aureus clones in Latin America from 1996 to 1998. J. Clin. Microbiol. 39:2197-2205.
3. Baba, T., F. Takeuchi, M. Kuroda, H. Yuzawa, K. Aoki, A. Oguchi, Y. Nagai, N. Iwama, K. Asano, T. Naimi, H. Kuroda, L. Cui, K. Yamamoto, and K. Hiramatsu. 2002. Genome and virulence determinants of high virulence community-acquired MRSA. Lancet 359:1819-1827.
4. Bannerman, T. L. 2003. Staphylococcus, Micrococcus, and other catalase-positive cocci that grow aerobically, p. 264-282. Manual of clinical microbiology, 8th ed. ASM Press, Washington, D.C.
5. Blake, J. T., and M. A. Metcalfe. 2001. A shared noncapsular antigen is responsible for false-positive reactions by Staphylococcus epidermidis in commercial agglutination tests for Staphylococcus aureus. J. Clin. Microbiol. 39:544-550.
6. Brakstad, O. G., K. Aasbakk, and J. A. Maeland. 1992. Detection of Staphylococcus aureus by polymerase chain reaction amplification of the nuc gene. J. Clin. Microbiol. 30:1654-1660.
7. Chung, M., H. de Lencastre, P. Matthews, A. Tomasz, I. Adamsson, M. Aires de Sousa, T. Camou, C. Cocuzza, A. Corso, I. Couto, A. Dominguez, M. Gniadkowski, R. Goering, A. Gomes, K. Kikuchi, A. Marchese, R. Mato, O. Melter, D. Oliveira, R. Palacio, R. Sa-Leao, I. Santos Sanches, J. H. Song, P. T. Tassios, and P. Villari. 2000. Molecular typing of methicillin-resistant Staphylococcus aureus by pulsed-field gel electrophoresis: comparison of results obtained in a multilaboratory effort using identical protocols and MRSA strains. Microb. Drug Resist. 6:189-198.
8. Clinical and Laboratory Standards Institute. 2005. Performance standards for antimicrobial disk susceptibility tests, approved standard, 8th ed.; and Performance standards for antimicrobial susceptibility testing, 15th informational supplement. M100-S15; for disk, M2-A-8; for MIC, M7-A6. Clinical and Laboratory Standards Institute, Wayne, Pa.
9. de Lencastre, H., E. P. Severina, H. Milch, M. K. Thege, and A. Tomasz. 1997. Wide geographic distribution of a unique methicillin-resistant Staphylococcus aureus clone in Hungarian hospitals. Clin. Microbiol. Infect. 3:289-296.
10. Doss, S. A. 1994. Chromosomally-mediated antibiotic resistance and virulence. J. Med. Microbiol. 40:305-306.
11. Duval-Iflah, Y., J. Van Heijenoort, M. Rousseau, and P. Raibaud. 1977. Lysogenic conversion for multiple characters in a strain of Staphylococcus aureus. J. Bacteriol. 130:1281-1291.
12. Enright, M. C., N. P. Day, C. E. Davies, S. J. Peacock, and B. G. Spratt. 2000. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J. Clin. Microbiol. 38:1008-1015.
13. Enright, M. C., D. A. Robinson, G. Randle, E. J. Feil, H. Grundmann, and B. G. Spratt. 2002. The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc. Natl. Acad. Sci. USA 99:7687-7692.
14. Finlay, J. E., L. A. Miller, and J. A. Poupard. 1997. Interpretive criteria for testing susceptibility of staphylococci to mupirocin. Antimicrob. Agents Chemother. 41:1137-1139.
15. Gase, K., J. J. Ferretti, C. Primeaux, and W. M. McShan. 1999. Identification, cloning, and expression of the CAMP factor gene (cfa) of group A streptococci. Infect. Immun. 67:4725-4731.
16. Giraudo, A. T., G. L. Martinez, A. Calzolari, and R. Nagel. 1994. Characterization of a Tn925-induced mutant of Staphylococcus aureus altered in exoprotein production. J. Basic Microbiol. 34:317-322.
17. Harbarth, S., P. Francois, J. Shrenzel, C. Fankhauser-Rodriguez, S. Hugonnet, T. Koessler, A. Huyghe, and D. Pittet. 2005. Community-associated methicillin-resistant Staphylococcus aureus, Switzerland. Emerg. Infect. Dis. 11:962-965.
18. Hiramatsu, K., H. Hanaki, T. Ino, K. Yabuta, T. Oguri, and F. C. Tenover. 1997. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J. Antimicrob. Chemother. 40:135-136.
19. Hoefnagels-Schuermans, A., W. E. Peetermans, M. J. Struelens, S. Van Lierde, and J. Van Eldere. 1997. Clonal analysis and identification of epidemic strains of methicillin-resistant Staphylococcus aureus by antibiotyping and determination of protein A gene and coagulase gene polymorphisms. J. Clin. Microbiol. 35:2514-2520.
20. Howe, R. A., A. Monk, M. Wootton, T. R. Walsh, and M. C. Enright. 2004. Vancomycin susceptibility within methicillin-resistant Staphylococcus aureus lineages. Emerg. Infect. Dis. 10:855-857.
21. Juuti, K. M., B. Sinha, C. Werbick, G. Peters, and P. I. Kuusela. 2003. Reduced adherence and host cell invasion by methicillin-resistant Staphylococcus aureus expressing the surface protein Pls. J. Infect. Dis. 189:1574-1584.
22. Krzyszton-Russjan, J., M. Gniadkowski, H. Polowniak-Pracka, E. Hagmajer, and W. Hryniewicz. 2002. The first Staphylococcus aureus isolates with reduced susceptibility to vancomycin in Poland. J. Antimicrob. Chemother. 50:1065-1069.
23. Krzysztoń-Russjan, J., J. Empel, T. Øȩski, M. Gniadkowski, and W. Hryniewicz. 2005. Clonal structure of the methicillin-resistant Staphylocccuos aureus (MRSA) population in Poland: revision and update. Microb. Drug Resist. 11:127-136.
24. Lina, G., F. Boutite, A. Tristan, M. Bes, J. Etienne, and F. Vandenesch. 2003. Bacterial competition for human nasal cavity colonization: role of staphylococcal agr alleles. Appl. Environ. Microbiol. 69:18-23.
25. Malachowa, N., A. Sabat, M. Gniadkowski, J. Krzyszton-Russjan, J. Empel, J. Miedzobrodzki, K. Kosowska-Shick, P. C. Appelbaum, and W. Hryniewicz. 2005. Comparison of multiple-locus variable-number tandem-repeat analysis with pulsed-field gel electrophoresis. spa typing, and multilocus sequence typing for clonal characterization of Staphylococcus aureus isolates. J. Clin. Microbiol. 43:3095-3100.
26. McDevitt, D., P. Francois, P. Vaudaux, and T. J. Foster. 1994. Molecular characterization of the clumping factor (fibrinogen receptor) of Staphylococcus aureus. Mol. Microbiol. 11:237-248.
27. McDevitt, D., P. Vaudaux, and T. J. Foster. 1992. Genetic evidence that bound coagulasc of Staphylococcus aureus is not clumping factor. Infect. Immun. 60:1514-1523.
28. McDevitt, D., E. Wann, and T. J. Foster. 1993. Recombination at the coagulase locus in Staphylococcus aureus: plasmid integration and amplification. J. Gen. Microbiol. 139:695-706.
29. McFaddin, J. F. 2000. Coagulase test, p. 105-119. Biochemical test for identification of medical bacteria. 3rd ed. Williams & Wilkins. Philadelphia. Pa.
30. Ni Eidhin, D., S. Perkins, P. Francois, P. Vaudaux, M. Hook, and T. J. Foster. 1988. Clumping factor B (ClfB). a new surface-located fibrinogen-binding adhesin of Staphylococcus aureus. Mol. Microbiol. 30:245-257.
31. Novick, R. P. 2003. Autoinduction and signal transduction in the regulation of staphylococcal virulence. Mol. Microbiol. 48:1429-1449.
32. Oliveira, D. C., and H. de Lencastre. 2002. Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 46:2155-2161.
33. Oliveira, D. C., A. Tomasz, and H. de Lencastre. 2002. Secrets of success of a human pathogen: molecular evolution of pandemic clones of methicillin-resistant Staphylococcus aureus. Lancet Infect. Dis. 2:180-189.
34. Projan, S. J., and R. P. Novick. 1997. The molecular basis of pathogenicity. p. 55-81. In K. B. Crossley and G. L. Archer (ed.), The staphylococci in human disease, 1st ed., vol. 3. Churchill Livingstone Inc., New York. N.Y.
35. Renzoni, A., P. Francois, D. Li, W. L. Kelley, D. P. Lew, P. Vaudaux, and J. Schrenzel. 2004. Modulation of fibronectin adhesins and other virulence factors in a teicoplanin-resistant derivative of methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 48:2958-2965.
36. Robinson, D. A., and M. C. Enright. 2003. Evolutionary models of the emergence of methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 47:3926-3934.
37. Sabat, A., J. Krzyszton-Russjan, W. Strzalka, R. Filipek, K. Kosowska, W. Hryniewicz, J. Travis, and J. Potempa. 2003. New method for typing Staphylococcus aureus strains: multiple-locus variable-number tandem repeat analysis of polymorphism and genetic relationships of clinical isolates. J. Clin. Microbiol. 41:1801-1804.
38. Sakoulas, G., G. M. Eliopoulos, V. G. J. Fowler, R. C. J. Moellering, R. P. Novick, N. Lucindo, M. R. Yeaman, and A. S. Bayer. 2005. Reduced susceptibility of Staphylococcus aureus to vancomycin and platelet microbicidal protein correlates with defective autolysis and loss of accessory gene regulator (agr) function. Antimicrob. Agents Chemother. 49:2687-2692.
39. Sakoulas, G., G. M. Eliopoulos, R. C. J. Moellering, R. P. Novick, L. Venkataraman, C. Wennersten, P. C. DeGirolami, M. J. Schwaher, and H. S. Gold. 2003. Staphylococcus aureus accessory gene regulator (agr) group II: is there a relationship to the development of intermediate-level glycopeptide resistance? J. Infect. Dis. 187:929-938.
40. Sakoulas, G., G. M. Eliopoulos, R. C. J. Moellering, C. Wennersten, L. Venkataraman, R. P. Novick, and H. S. Gold. 2002. Accessory gene regulator (agr) locus in geographically diverse Staphylococcus aureus isolates with reduced susceptibility to vancomycin. Antimicrob. Agents Chemother. 46:1492-1502.
41. Savolainen, K., L. Paulin, B. Westerlund-Wikstrom, T. J. Foster, T. K. Korhonen, and P. Kuusela. 2001. Expression of pls, a gene closely associated with mecA gene of methicillin-resistant Staphylococcus aureus, prevents bacterial adhesion in vitro. Infect. Immun. 69:3013-3020.
42. Schwartz, D. C., and C. R. Cantor. 1984. Separation of yeast chromosome-sized DNAs by pulsed field gradient gel electrophoresis. Cell 37:67-75.
43. Smeltzer, M. S., A. F. Gillaspy, F. L. J. Pratt, M. D. Thames, and J. J. Iandolo. 1997. Prevalence and chromosomal map location of Staphylococcus aureus adhesin genes. Gene 196:249-259.
44. Soussy, C. J., G. Carret, J. D. Cavallo, H. Chardon, C. Chidiac, P. Choutet, P. Courvalin, H. Dabernat, H. Drugeon, L. Dubreuil, F. Goldstein, V. Jarlier, R. Leclercq, M. H. Nicolas-Chanoine, A. Philippon, C. Quentin, B. Rouveix, and J. Sirot. 2000. Antibiogram Committee of the French Microbiology Society. Report 2000-2001. Pathol. Biol. (Paris) 48:832-871. (In French.)
45. Szymanowska, A., A. Sawicka-Grzelak, A. Mlynarczyk, and G. Mlynarczyk. 1993. Evaluation of drug sensitivity and biochemical properties of coagulase-negative S. aureus strains isolated from clinical specimens. Med. Dosw. Mikrobiol. 45:11-14.
46. Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
47. Trakulsomboon, S., S. Danchaivijitr, Y. Rongrungruang, C. Dhiraputra, W. Susaemgrat, T. Ito, and K. Hiramatsu. 2001. First report of methicillin- resistant Staphylococcus aureus with reduced susceptibility to vancomycin in Thailand. J. Clin. Microbiol. 39:591-595.
48. Vandenesch, F., C. Lebeau, M. Bes, D. McDevitt, T. Greenland, R. P. Novick, and J. Etienne. 1994. Coagulase deficiency in clinical isolates of Staphylococcus aureus involves both transcriptional and post-transcriptional defects. J. Med. Microbiol. 40:344-349.
49. Vandenesch, F., T. Naimi, M. C. Enright, G. Lina, G. R. Nimmo, H. Heffernan, N. Liassine, M. Bes, T. Greenland, M. E. Reverdy, and J. Etienne. 2003. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg. Infect. Dis. 9:978-984.
50. Vaudaux, P. E., V. Monzillo, P. Francois, D. P. Lew, T. J. Foster, and B. Berger-Bachi. 1998. Introduction of the mec element (methicillin resistance) into Staphylococcus aureus alters in vitro functional activities of fibrinogen and fibronectin adhesins. Antimicrob. Agents Chemother. 42:564-570.
51. Verdier, I., M. E. Reverdy, J. Etienne, G. Lina, M. Bes, and F. Vandenesch. 2004. Staphylococcus aureus isolates with reduced susceptibility to glycopeptides belong to accessory gene regulator group I or II. Antimicrob. Agents Chemother. 48:1024-1027.
52. Walsh, T. R., A. Bolmstrom, A. Qwarnstrom, P. Ho, M. Wootton, R. A. Howe, A. P. MacGowan, and D. Dickema. 2001. Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides. J. Clin. Microbiol. 39:2439-2444.
53. Wilkerson, M., S. McAllister, J. M. Miller, B. J. Heiter, and P. P. Bourbeau. 1997. Comparison of five agglutination tests for identification of Staphylococcus aureus. J. Clin. Microbiol. 35:148-151.
54. Wootton, M., P. M. Bennett, A. P. MacGowan, and T. R. Walsh. 2005. Reduced expression of the ad autolysin gene and susceptibility to autolysis in clinical heterogeneous glycopeptide-intermediate Staphylococcus aureus (hGISA) and GISA strains. J. Antimicrob. Chemother. 56:944-947.